DHANUKA Laboratories Ltd.

Dhanuka Laboratories Limited is one of the prominent manufacturer and exporter of ORAL CEPHALOSPORIN APIs based in India. The company has a large capacity to manufacture various products like Cefixime, Cefdinir, Cefaclor, Cefuroxime Axetil, Cefpodoxime Proxetil, Cefditoren Pivoxil, Cefprozil in high quality cGMP conditions.

The company strives to maintain high ethical values and customer-centric policy. The motto of the company is to provide the right product at the right price at the right time to the customer.

Dhanuka Laboratories Limited is proud to be a WHO-GMP, ISO 9001-2015 certified company.

The company values intellectual property and hence the company invests regularly in to Research & Development and generate its own intellectual property rights through filing of patents regularly.

About Us

"Dhanuka Group", which has an annual sales of Rs. 1000cr (USD 200 Million). Dhanuka Group is a three decade old business house that has been engaged in the business of Agrochemicals and Pesticides. The group garnered a high reputation by virtue of its ethics and was able to have Global tie-ups with internationally reputed companies in Agrochemicals. Having attained a prominence in their core forte, the group decided to diversify into pharmaceuticals and established Dhanuka Laboratories Ltd. In 1998.

Right from inception, Dhanuka Laboratories Ltd. has adopted synergistic advantage to develop and manufacture a range of Cephalosporin’s and their key intermediates. With age, the company has matured into a formidable contender that has outperformed its peers in terms of Quality and Reliability.

Dhanuka Laboratories Ltd. Has established itself as a respected vendor of Active Pharmaceutical Ingredients in the International market, with exports of its products to more than 20 countries. The company has strived to continuously improve quality standards, by registering its products in most stringent international markets like European Union, China, Korea and Japan. The company’s GMP standards have been audited by many reputed customers in India and abroad, and found to be appropriate. The company is in the process of getting approvals from EDQM and KFDA.

After establishing in the field of API, Dhanuka Laboratories Ltd aspired to develop into an Integrated Pharmaceutical company, and this resulted in acquisition of Pharmceutical Formulations exporting company “Synmedic Laboratories”. Synmedic Laboratories has a strong global presence with more than 500 product registrations in more than 15 countries. Synmedic has strong presence across therapeutic categories which include Anti-infectives, cardiovascular, Antiretroviral, Gastroenterology Pain management, Dermatology and many more.

Dhanuka Laboratories is focused on its mission to deliver excellence in every corner of its operations and meet its commitments to the many constituencies that it serves. All the long term strategies and short term actions are molded by a set of core values that are shared by each and every associate.

The company’s desire to have technical and commercial tie ups in developed and developing geographies of the world will help it to achieve a wider goal of “Healthcare for all”. In an integral approach to healthcare that fuses traditional wisdom with technological sophistication, the company is focussed on it larger motto “Life Enrichment through Science”.